Lenz & Staehelin: Jefferies underwriter for ADC’s public offering of shares

Lenz & Staehelin has advised investment bank Jefferies as underwriter in the public offering of shares of the Lausanne based ADC Therapeutics, a commercial-stage biotechnology company helping to improve the lives of those affected by cancer and listed on the New York Stock Exchange.

There were 12M shares sold at a price of USD 5 per share, resulting in a total deal value of USD 60M. The shares were sold by a shareholder and not by ADC. The offering included participation from Redmile Group, Perceptive Advisors, Frazier Life Sciences and Surveyor Capital (a Citadel company) along with other institutional investors. Jefferies acted as sole book-running manager for the offering.

The Lenz & Staehelin team included partner and head of capital markets Jacques Iffland (pictured left) and partner Ariel Ben Hattar (capital markets and fintech, pictured right).

Lenz & Staehelin: Jefferies underwriter for ADC’s public offering of shares



Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram